🔎 Trials Near Me

መነሻ › የእንቁላል ካንሰር › Texas › Fort Worth

በFort Worth፣ TX ለየእንቁላል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየእንቁላል ካንሰር የሚደረጉ 17 ጥናቶች በFort Worth እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07001748

A Study of PHST001 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • START Center for Cancer Research - Texas, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06840886

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • START Center for Clinical Research, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06270706

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Texas Oncology - Fort Worth Cancer Center /ID# 275043, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06890338

A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Texas Oncology - DFW ( Site 8005), Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07776691

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Texas Oncology - Fort Worth Cancer Center /ID# 277989, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07059845

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Jps Health Network, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07214779

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Start Dfw, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06303505

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Start - Dfw, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06293898

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Texas Oncology - DFW ( Site 8001), Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06824467

Study of NTB-928 in R/R OC

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Start Ccbd, Llc, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ20 ኦገስ 2026 · NCT07690189

Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Xencor Investigative Site, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ13 ኦገስ 2026 · NCT07593092

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT06580314

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • USOR Texas Oncology, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT05579366

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Texas Oncology Paris, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ጁላይ 2026 · NCT06161025

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • START Dallas, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT07517198

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • SCRI - Texas Oncology, Fort Worth
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ23 ዲሴም 2025 · NCT06690775

በሌሎች ከተሞች ለየእንቁላል ካንሰር የሚደረጉ ጥናቶች

በFort Worth ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።